IBI355

N/A

Report date: 2025/04/07 15:07:35

Base Information

Drug NameIBI355
Drug Alias NameIBI-355
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCD40 ligand modulators
TargetsCD40 ligand
Therapy Area/IndicationsLupus Erythematosus, SystemicSjogren's Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInnovent Biologics(Suzhou) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesInnovent Biologics(Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicSjogren's Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A